Releases: pc4covid19/pharmacodynamics-submodel
Version 0.3.1
Update cell fusion process:
- Add a new function called
fuse_cell
in thePhysiCell_cell.cpp
ofcore
folder - Update the fusion probablity (scaled with cell A's intracellular assembled virions and cell B's unbound ACE2)
- Update fused cell’s intracellular virion reaction rates (scaled with RNA threshold)
Version 0.3.0
Add model of cell fusion
process in this version of release:
- The conditions for cell fusion:
- population of intracellular assembled virion is greater than a threshold
- distance of two potential fused cells is smaller than a threshold
- frequency of cell fusion is smaller than a threshold (in case a cell can become fused many times)
- randomly sampled probability is smaller than the probability of cell fusion (which is positively corrected with the population of intracellular assembled virion)
- If cell fusion happened, then:
- new fused cell’s position is the mean of two cells
- new fused cell’s volume will be updated
- population of ACE2 as well as intracellular virion will be updated
- new fused cell’s intracellular virion can replicate faster (with increasing uncoating RNA and protein synthesis rates). In addition, fused cell also has larger viral tolerant capability (with increasing half of maximum apoptosis rate).
- The effect of drug on cell fusion and virial spread:
- drug only inhibits cell fusion (through reduce the probability of cell fusion)
- drug only inhibits endocytosis and exocytosis
- drug inhibits both cell fusion, and endocytosis, exocytosis
Version 0.2.0
This release matches with version used in the paper Maraviroc inhibits SARS-CoV-2 multiplication and s-protein mediated cell fusion in cell culture
In this release:
- Use intracellular drug concentration in calculating drug effect
- Update receptor dynamics, replication dynamics, export rate parameters and EC_50 to match with experimental data
- Add negative feedback for ACE2 binding, endocytosis process
- Pick up 3000 cells randomly binded with virion, rather than internalization in the beginning
- Use Dirichlet nodes for all voxels in the simulation
Version 0.1.0
COVID19 pharmacodynamics-submodel
This model simulates the COVID19 pharmacodynamics response. See https://github.com/pc4covid19/COVID19 for full model information.
To model the single-cell pharmacodynamics, we first modeled the rate of drug internalization as diffusion through the cell membrane, allowing us to track the accumulated total drug in each cell. Then, we model the total effect E for each cell based on the internal drug concentration using a Hill function. The effect is then used to modulate a vector r of cell parameters from their untreated rates r_0 to their rates at maximum drug efficacy r_max when E = Emax. In this investigation, r includes the ACE2 dynamics, viral replication and export rate. In addition, we can model the impact of partial drug efficacy by multiplying the effect by a sensitivity S, where S = 0 denotes a drug with no efficacy (e.g., it fails to bind its target), and S = 100% is an idea drug that fully binds and inhibits its target.
You can try to run our cloud-hosted nanoHUB app for fun!
https://nanohub.org/tools/virion2pbpd
Release summary:
0.1.0:
This is initial release.